Literature DB >> 16165350

The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines.

Gennady B Lapa1, Gary D Byrd, Alla A Lapa, Evgeny A Budygin, Steven R Childers, Sara R Jones, Jill J Harp.   

Abstract

The synthesis of potent 4-aryl methoxypiperidinol inhibitors of the dopamine transporter is described. Symmetrical para substituents of the benzene rings are important for high potency in binding to the dopamine transporter. 4-[Bis(4-fluorophenyl) methoxy]-1-methylpiperidine has an IC50 of 22.1+/-5.73 nM and increases locomotor activity in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165350     DOI: 10.1016/j.bmcl.2005.08.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.

Authors:  Nidhi Kaushal; Matthew J Robson; Harsha Vinnakota; Sanju Narayanan; Bonnie A Avery; Christopher R McCurdy; Rae R Matsumoto
Journal:  AAPS J       Date:  2011-04-15       Impact factor: 4.009

2.  Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.

Authors:  Erik B Oleson; Mark J Ferris; Rodrigo A España; Jill Harp; Sara R Jones
Journal:  Eur J Pharmacol       Date:  2012-03-15       Impact factor: 4.432

3.  Vascular effects of diphenylmethoxypiperidine-derived dopamine uptake inhibitors.

Authors:  Victor M Pulgar; Jill Keith Harp
Journal:  Bioorg Med Chem Lett       Date:  2014-04-18       Impact factor: 2.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.